
European Commission Grants Approval of Ritlecitinib for Severe Alopecia Areata
Doug BrunkThe European Commission has authorized the marketing of ritlecitinib to treat adults and adolescents 12 years of age and older with severe alopecia areata.This makes ritlecitinib the f
Updated on: October 26,2023
12

European Commission Grants Approval of Ritlecitinib for Severe Alopecia Areata
Doug BrunkThe European Commission has authorized the marketing of ritlecitinib to treat adults and adolescents 12 years of age and older with severe alopecia areata.This makes ritlecitinib the f
Updated on:October 26,2023
12
